HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,337-6,348 of 27,277
Drug study icon
CompletedNCT00604279

A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in people with Schizophrenia

What is this study about?

Researchers compared Paliperidone palmitate (R092670) and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Baoding
SchizophreniaMedication studyAges 18+
Countries
China
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Drug study icon
TerminatedNCT01592201

Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER for Schizophrenia

Official study title

An Open-label, Prospective, Randomized and Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

This study ended early.

Multiple locations, including Busan
SchizophreniaMedication studyAges 20–65
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Drug study icon
CompletedNCT01682161

Evolution of Medication Satisfaction and Adherence for Schizophrenia

Official study title

An Open-Label, Comparative Study of Immediate or Delayed Switch to Paliperidone Palmitate in Patients Unsatisfied With Current Oral Atypical Antipsychotics to Evaluate the Evolution of Medication Satisfaction and Adherence

This study has finished and is no longer accepting participants.

Multiple locations, including Buchun
SchizophreniaMedication studyAges 20–65
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Drug study icon
CompletedNCT01086748

A Comparator Study of LY2140023 Versus Placebo in Schizophrenia Patients

What is this study about?

Researchers compared LY2140023, Risperidone and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Escondido
SchizophreniaMedication studyAges 18–65
Countries
United States, Croatia, Russia
Sponsor
Denovo Biopharma LLC
Behavioral study icon
CompletedACTRN12619000085178

A comparison between computer based Positive Search Training and Cognitive Behavioural Training in children with anxiety disorders an Australian Childhood Anxiety Treatment Study (A-CATS)

Official study title

Improving access to treatment for children with anxiety disorders: A randomised controlled non-inferiority trial between positive search training and cognitive behavioural training for anxiety

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 7–12
Countries
Australia
Sponsor
Griffith University
Behavioral study icon
CompletedACTRN12615001052527

A comparison in early high school students of the effect of an 8 week course of mindfulness (with and without parental involvement) versus normal school lessons on anxiety, depression, Eating disorders risk factors and wellbeing

Official study title

A randomised controlled trial of a the ".b" mindfulness in schools curriculum (standard version) versus a modified version (with parental involvement) versus normal lessons in Year 8 male and female Australian students to assess impact on anxiety, depression, weight/shape concerns and wellbeing (primary outcome factors) and mindfulness (secondary outcome factor).

This study has finished and is no longer accepting participants.

In Australia
Depression, Eating disorders, ...Interventional studyAges 11–16
Countries
Australia
Sponsor
Flinders University
Behavioral study icon
CompletedACTRN12615001051538

A comparison in early high school students of the effect of an 8 week course of mindfulness versus normal school lessons on anxiety, depression, Eating disorders risk factors and wellbeing

Official study title

A randomised controlled trial of a the ".b" mindfulness in schools curriculum versus normal lessons in Year 8 male and female Australian students to assess impact on anxiety, depression, weight/shape concerns and wellbeing (primary outcome factors) and self-compassion, difficulties in emotional regulation and mindfulness (secondary outcome factors).

This study has finished and is no longer accepting participants.

In Australia
Depression, Eating disorders, ...Interventional studyAges 11–16
Countries
Australia
Sponsor
Flinders University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.